Navigation Links
Actinobacillus pleuropneumoniae

Multiporator / Electroporator 2510 Transformation Protocol Protocol No. 4308 915.539 04/2002 Microorganism Actinobacillus pleuropneumoniae Cell type Bacteria, gram negative Molecules injected Plasmid DNA (in water) Growth medium Columbia broth with 1% IsoVitaleX and 10 g/ml -NAD Washing solution 15% glycerine Electroporation solution 15% glycerine Outgrowth medium Columbia broth with 1% IsoVitaleX and 10 g/ml -NAD Cuvette 2 mm gap width Reference Frey, J. 1992 Research in Microbiology 143 263-269

Making electrocompetent cells:

1. Grow cells to mid-exponential growth phase at an O.D.650of 0.5.
2. Harvest by centrifugation at 3,000 x g for 10 min at 4 C.
3. Wash twice in 15% glycerine at 4 C.
4. Resuspend in 1/20 volume of 15% glycerine and keep at 4 C.

Electroporation of cells:

1. Add 3 l (300 g/ml) plasmid DNA to 125 l of electrocompetent cells. Homogenize by gently mixing with pipette
several times. Transfer mixture into a prechilled cuvette.
2. Wipe moisture from the cuvette and insert the cuvette into the device.
3. Electroporation:

Mode Prokaryotes O Voltage (V) 1,250 V Time constant (T) 5 ms
4. Immediately add 1 ml outgrowth medium and incubate for 3 h.
5. Plate onto selective Columbia agar plates.

Expected results:

Transformation efficiency up to 1 x 107 transformants/g of DNA.


'"/>

Source:


Page: All 1 2

Related biology technology :

1. Actinobacillus pleuropneumoniae
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... A research team led by ... in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. The article ... coronary artery disease (CAD). Lam is an assistant professor at the Department of ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March 24, ... Maxwell Biotech Venture Fund (MBVF), today announced positive results ... to the standard drug therapy regimen in patients with ... molecule drug discovered by scientists at Sequella, Inc. ( ... of Health. A total of 140 ...
(Date:3/24/2017)... Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company ... vaccines, today announced participation at the following conferences: ... and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at ... New York, NY . Agenus will participate in ... am: Robert B. Stein , M.D., Ph.D., President, ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
Breaking Biology Technology:
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
Breaking Biology News(10 mins):